Celerion is an science-driven international CRO specialized in bioanalysis and early clinical development services. Our focus is to deliver comprehensive early drug development and clinical pharmacology services that enable clients to get their products to market faster and assist them in making informed go/no-go decisions in drug development earlier. Services include:
- Global Clinical Research (Phase I and NDA-enabling clinical pharmacology study conduct)
- Global Clinical Development (access to Phase I and II multi-site studies in healthy subjects and patients)
- Data Management and Biometrics (modeling and simulation, study design and protocol development, clinical data sciences, biostatistics, PK/PD, medical writing and reporting)
- Global Bioanalytical Services (discovery to late stage services with capabilities in small and large drug, metabolite and biomarker molecules)
- Drug Development Services (program and project management, regulatory services and drug development consultancy)
